Chief Physician, Level 2 Professor, Doctoral Supervisor, Director of Nephrology Department, and Director of the Nephrology Research Institute
Affiliated HospitalWest China Hospital of Sichuan University
→
-Research areas : Diabetic nephropathy, severe acute kidney injury, blood purification, large-scale cohort studies of chronic kidney disease, pathogenesis and prevention of metabolic kidney diseases (with a focus on diabetic nephropathy, hypertensive nephropathy, and hyperuricemic nephropathy); various primary and secondary kidney diseases; acute and chronic renal failure.
- Cutting-edge technologies: Simplified citrate anticoagulation CRRT, CKD three-in-one follow-up management system, construction and promotion of continuous renal replacement therapy (CRRT) system; integrated care model for CKD; hemodialysis, peritoneal dialysis, etc.
- Areas of expertise: IgA nephropathy, lupus nephritis, diabetic nephropathy, acute and chronic renal failure, hypertensive nephropathy, and uric acid nephropathy.
- Academic Highlights: Standing Committee Member of the 8th, 9th, and 10th Sessions of the Chinese Society of Nephrology; Standing Committee Member of the Chinese Medical Doctor Association Nephrology Branch; Vice President of the World Chinese Nephrologists Association; Academic and Technical Leader of Sichuan Province; Recipient of the International Society of Nephrology (ISN) Fellowship; Head of a sub-project of the National Key Research and Development Program; Top 2% of scientists globally; Pioneered the establishment of a long-term follow-up center for CKD in China; Responsible for more than 20 projects including the National 863 Program, the National 973 Program, and the National Natural Science Foundation of China; Published nearly 400 papers (more than 130 SCI papers); Received 5 awards including the Chinese Medical Association Science and Technology Progress Award; Authorized 7 national invention and utility model patents; Chief Editor of "Continuous Renal Replacement Therapy". Core Values: Establishing a standardized treatment system for severe AKI in China and promoting homogenized diagnosis and treatment of kidney diseases in western China.